Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
The current Editas Medicine(EDIT) stock price is $2.33, with a market capitalization of 226.96M. The stock trades at a price-to-earnings (P/E) ratio of -0.84.
During the trading session on 2026-03-09, Editas Medicine(EDIT) shares reached a daily high of $2.47 and a low of $1.93. At a current price of $2.33, the stock is +20.5% higher than the low and still -5.9% under the high.
Trading activity shows a volume of 3.66M, compared to an average daily volume of 1.96M.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
Over the past 52 weeks, Editas Medicine(EDIT) stock has traded between a high of $4.54 and a low of $0.91.
EDIT News
Editas Medicine (EDIT) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to loss of $1 per...
Reports Q4 revenue $24.741M vs $30.604M last year. “We achieved notable progress in the fourth quarter of 2025 as we advanced our mission and strategy to become...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.